| Abstrakt: |
Introduction and Objective and Methods: Hepatitis C is one of the major health problems around the world. According to the World Health Organization, the prevalence of this disease is about 3%. Patients with renal failure undergoing hemodialysis are at risk for various infections, including hepatitis C. Immune system disorders and transmission of contamination during supportive treatments such as blood transfusion in anemic patients, and the inadequate disinfection of hemodialysis devices, increase the risk of transmission of diseases such as hepatitis C. Serum levels of liver enzymes, serological examination of hepatitis C antibodies, qualitative and quantitative molecular analysis, determination of viral genotype, liver biopsy, and histological examination, are methods that help diagnose, determine the type and extent of disease progression. In order to reduce the transmission rate and the risk of hepatitis C, we decided to review the studies to providing a small assistance for these patients, especially for high risk groups, to reduce their risk of infection. Results and Conclusions: Due to the lack of a specific vaccine for the prevention and control of hepatitis C infection, care of patients against the infection has a significant impact on reducing their mortality. [ABSTRACT FROM AUTHOR] |
